The fifth annual Apheresis Awareness Day is recognized on Tuesday, September 17, 2024, as designated by the American Society for Apheresis (ASFA). The purpose is to raise awareness of apheresis ...

Lipoprotein apheresis involves the extracorporeal removal of LDL and lipoprotein(a) particles from whole blood or plasma by adsorption, precipitation or differential filtration. Used repetitively ...

The global therapeutic apheresis market is poised for steady growth, forecasted to reach USD 4,285.0 million by 2035, up from USD 2,922.7 million in 2025, registering a CAGR of 3.9% over the forecast ...

Rising Demand for Blood Components: The growing demand for blood components is a significant factor contributing to the expansion of the apheresis market. Hospitals and clinics significantly ...

Bendamustine treatment before apheresis is known to reduce survival in large B-cell lymphoma (LBCL) patients receiving chimeric antigen receptor (CAR) T-cell therapy. Bendamustine has been shown ...

“The Transfusion Medicine Service in the Department of Pathology performs therapeutic apheresis on patients who have an illness associated with an abnormal cellular or plasma-based blood component,” ...

Separating the other components of blood, like platelets and white blood cells, requires another kind of blood donation called apheresis. During an apheresis donation, our teams collect blood from ...

The center will specialize in collecting concentrated white blood cell biospecimens through apheresis (a.k.a. leukopaks) from participants in Sanguine’s Patient Community network. These research ...

Apheresis is the process of removing blood from a patient while using a special machine to separate the different components of blood. One or more components are removed to use in treatments or ...

The recently published results of a Phase III study of the MTP inhibitor lomitapide suggests that this drug may become a useful adjunct to Lp apheresis in the future. [61] The study involved ...